Navigation Links
CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal

in developing RNAi therapeutics."

Steven A. Kriegsman, President and CEO of CytRx, added, "RNAi therapeutics holds tremendous promise as cures for diseases caused by proteins that cannot be targeted by conventional drugs. We are pleased that Dr. Rana and his colleagues are receiving recognition from the scientific community in developing a breakthrough that could expedite the development of important therapeutic treatments."

About CytRx Corporation

Los Angeles, California-based CytRx Corporation is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics. The Company owns three clinical-stage compounds based on its small molecule "molecular chaperone" co-induction technology. In September 2006 CytRx announced that arimoclomol was shown to be safe and well tolerated at all three doses tested in its Phase IIa clinical trial in patients with ALS. The Company expects to announce results of its completed open-label extension trial in the second quarter of 2007. The Company plans to enter a Phase IIb clinical trial with arimoclomol in ALS in the second half of 2007, subject to U.S. Food and Drug Administration (FDA) acceptance. The FDA has granted Fast Track designation and Orphan Drug status to arimoclomol for the treatment of ALS and has also been granted orphan medicinal product status for the treatment of ALS by the European Commission. The Company is also developing a potential Phase II clinical plan for arimoclomol in stroke recovery. For more information on the Company, visit www.cytrx.com.

About RXi Pharmaceuticals Corporation

Worcester, Massachusetts-based RXi Pharmaceuticals Corporation, a majority-owned subsidiary of CytRx Corporation, is a biopharmaceutical research and development company that focuses on developing RNAi-based therapeutics for the treatment of human disease. RXi's initial focus is on neurodegenerative diseases, oncology, type 2 diabetes and obesity. RXi
'"/>




Page: 1 2 3 4

Related medicine technology :

1. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
2. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:7/31/2014)... , July 31, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... of multiple strains of cannabis and European Union ... select the best strains for development of proprietary ... cannabis formulations to market for critical ailments such ...
(Date:7/31/2014)... , July 31, 2014 For the first ... watch the implantation of the SynCardia temporary Total Artificial ... matching video posted on the Journal of Visualized Experiments ... read the paper on the SynCardia Total Artificial Heart ... video accompanies "Implantation of the SynCardia Total Artificial Heart," ...
(Date:7/31/2014)... 2014 TB Alliance, a not-for-profit with ... and affordable treatments, announced the appointment of ... Affairs. Mr. Brock comes to TB Alliance having ... Relations for WWF International (formerly known as the ... will guide the TB Alliance,s resource development, advocacy ...
Breaking Medicine Technology:Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... Pharmaceutical and biotech companies reach much greater and ... R&D and marketing, balancing therapeutic innovation with commercial focus ... to break down the walls that have traditionally separated ... both talented medical researchers and skillful marketers. ...
... Oct. 6 Surgeons at Self Regional Healthcare,s South ... patients with a variety of spinal conditions in its ... from Brainlab. Already recognized by leading health ... program, Self Regional continues its commitment to advanced spinal ...
Cached Medicine Technology:Creating Partnerships Across R&D and Marketing to Ensure a Successful Global Launch 2Self Regional Healthcare Becomes First in the Southeast to Treat Spine Patients Using Advanced Integrated Operating Room Technology From Brainlab 2
(Date:7/31/2014)... Albany, NY (PRWEB) July 31, 2014 ... Review, H2 2014, provides an overview of the ... comprehensive information on the therapeutic development for Brain ... therapeutics assessment by drug target, mechanism of action ... along with latest updates, and featured news and ...
(Date:7/31/2014)... July 31, 2014 The North America Phytochemicals ... & plant extracts market in North America with analysis and ... from around $576.3 million in 2012 to $930.1 million by ... , Browse through the TOC of the North America phytochemicals ... the in-depth analysis provided. It also provides a glimpse of ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 My ... into strategic alliance with Dr. Lawrence Wasserman, Managing ... content to http://www.mymobileuni.com its global health ... http://www.mymobileuni.net/mu3/health.php will include courses, e-books and other ... to learn, re-skill or up-skill themselves in the ...
(Date:7/31/2014)... new report finds that by 2010, one in every 10 ... the greatest rise among those aged 25 to 44. ... found the number of office visits for patients with diabetes ... and 2010. Almost 29 million Americans have diabetes, the ... $245 billion each year. Diabetes falls into two categories: Type ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Throughout ... Coalition will be featured in the highly coveted ... being donated by EHE International, an historic preventative ... The eye-catching window display, designed in partnership with ... women’s footsteps, in a ratio that denotes the ...
Breaking Medicine News(10 mins):Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 3Health News:Global Brain Cancer Market Size, Share, Analysis, Trends and Forecasts 2014 4Health News:North America Phytochemicals & plant extracts (Nutraceuticals) Market is Expected to Reach $930.1 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Phytochemicals & plant extracts (Nutraceuticals) Market is Expected to Reach $930.1 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Phytochemicals & plant extracts (Nutraceuticals) Market is Expected to Reach $930.1 Million in 2018 - New Report by MicroMarket Monitor 4Health News:MyMobileUniversity and Fortech International Form Strategic Alliance That Will Enhance the Global Health and Medical Channel on Its Website 2Health News:Big Jump in Doctor's Office Visits for Young Adults With Diabetes 2Health News:National Ovarian Cancer Coalition to be Featured in New York’s Rockefeller Center Window during August to Raise Awareness and Promote Education about Ovarian Cancer 2Health News:National Ovarian Cancer Coalition to be Featured in New York’s Rockefeller Center Window during August to Raise Awareness and Promote Education about Ovarian Cancer 3
... A diverse coalition of,clergy and lay members from ... U.S. Senators John Warner (R-VA) and Jim Webb ... legislation that gives,the U.S. Food and Drug Administration ... kids from tobacco and save lives., Despite ...
... Just one week after Cover,All Pennsylvanians, the centerpiece ... Legislature, Governor Edward G. Rendell today kicked,off a ... meeting in Pittsburgh.,The five-day, nine-stop tour will highlight ... coverage. Allegheny County, the location of the kick-off,event, ...
... who experience chronic job strain after a first heart ... one, reports a research team from Universit Lavals Faculty ... Journal of the American Medical Association. , This study ... with job strain for workers who have been victim ...
... Actor Joe Pantoliano,reveals a personal history of ... untreated bipolar disorder, in a guest blog entry, ... on Mental,Illness (NAMI)., Pantoliano,s entry comes during ... days before the opening of his latest film, ...
... finds , , TUESDAY, Oct. 9 (HealthDay News) -- Maintenance ... it off, new research suggests. , However, the study ... wears off over time, suggesting the need for longer ... , "We were excited by the results of ...
... 2007 Eugene Garfield Economic Impact of Medical and ... Tomas Philipson,Ph.D., and Anupam Jena, Ph.D., were honored ... published in Forum for Health Economics and,Policy., ... the value of,HIV/AIDS drugs developed from 1980 to ...
Cached Medicine News:Health News:Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco 2Health News:Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco 3Health News:Governor Rendell Launches 'Tour to Insure;' Urges Passage of Plan to Give Access to Affordable Health Insurance 2Health News:Governor Rendell Launches 'Tour to Insure;' Urges Passage of Plan to Give Access to Affordable Health Insurance 3Health News:Chronic job strain doubles the risk of a second heart attack 2Health News:Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side 2Health News:Maintenance Treatment Helps Kids Keep Weight Off 2Health News:Maintenance Treatment Helps Kids Keep Weight Off 3Health News:Maintenance Treatment Helps Kids Keep Weight Off 4Health News:Research!America Honors Univ. of Chicago Economists for Study Showing Economic Impact of HIV/AIDS Drug Development 2
... PROXIMATE Access 55 Articulating Linear Staplers are ... or a thick-tissue green instrument (non-reloadable). Each ... 55mm staple line., ,Benefits include: , ... in narrow male pelvis. , Articulating head ...
... Staplers deliver two staggered rows of titanium staples ... be reloaded up to three times for a ... wire staples for thick tissue. The TLV model ... ,Benefits include: , Parallel jaw closure ensures that ...
... Loading Units With Titanium Staples ... TA™ (Single Use Reloadable Stapler ... Auto Suture™ PREMIUM MULTIFIRE TA™ ... gynecological, pediatric and thoracic surgical ...
Single Use Reloadable Stapler with Titanium Staples., ,The Auto Suture™ PREMIUM MULTIFIRE TA™ stapler has applications in abdominal, gynecological, pediatric and thoracic surgical proced...
Medicine Products: